Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MENT
1001
DELISTED
Mentor Graphics Corp
MENT
| $9.68M | 0.02% |
366,289
+82,769
| +29% | +$2.1M |
|
1002
Ford
F
$55.5B
| $9.67M | 0.02% |
+644,408
| New | +$9.99M |
|
1003
International Paper
IP
$21.7B
| $9.66M | 0.02% |
214,430
-351,221
| -62% | -$17.4M |
|
1004
Fossil Group
FOSL
$329M
| $9.64M | 0.02% |
139,002
+44,482
| +47% | +$3.46M |
|
1005
ServiceNow
NOW
$132B
| $9.64M | 0.02% |
648,425
-853,375
| -57% | -$13.2M |
|
|
MDCO
1006
DELISTED
Medicines Co
MDCO
| $9.63M | 0.02% |
336,736
-1,122,880
| -77% | -$31.3M |
|
1007
Kratos Defense & Security Solutions
KTOS
$9.96B
| $9.61M | 0.02% |
1,525,521
-280,381
| -16% | -$1.66M |
|
1008
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
| $9.61M | 0.02% |
81,826
+52,759
| +182% | +$6.47M |
|
1009
Nu Skin
NUS
$232M
| $9.56M | 0.02% |
202,783
+198,783
| +4,970% | +$10.8M |
|
1010
Advance Auto Parts
AAP
$2.63B
| $9.54M | 0.02% |
59,917
-795,476
| -93% | -$122M |
|
|
CPN
1011
DELISTED
Calpine Corporation
CPN
| $9.49M | 0.02% |
527,557
-3,757,504
| -88% | -$78.4M |
|
1012
Bristol-Myers Squibb
BMY
$137B
| $9.48M | 0.02% |
142,471
-1,193,515
| -89% | -$78.7M |
|
1013
iShares China Large-Cap ETF
FXI
$4.24B
| $9.47M | 0.02% |
205,336
-32,264
| -14% | -$1.6M |
|
|
HDP
1014
DELISTED
Hortonworks, Inc.
HDP
| $9.46M | 0.02% |
+373,659
| New | +$8.97M |
|
1015
Compañía de Minas Buenaventura
BVN
$8.94B
| $9.43M | 0.02% |
+908,821
| New | +$9.96M |
|
1016
Wabash National
WNC
$491M
| $9.42M | 0.02% |
751,045
-71,858
| -9% | -$1M |
|
1017
FTI Consulting
FCN
$4.29B
| $9.39M | 0.02% |
227,608
+220,584
| +3,140% | +$8.79M |
|
|
SIVB
1018
DELISTED
SVB Financial Group
SIVB
| $9.38M | 0.02% |
65,160
-326,775
| -83% | -$44.2M |
|
|
DRRX
1019
DELISTED
DURECT Corp
DRRX
| $9.38M | 0.02% |
392,276
+305,579
| +352% | +$7.18M |
|
1020
uniQure
QURE
$3.29B
| $9.37M | 0.02% |
347,037
+151,789
| +78% | +$4.32M |
|
1021
First Solar
FSLR
$22.4B
| $9.33M | 0.02% |
198,560
-589,443
| -75% | -$32.9M |
|
|
WOOF
1022
DELISTED
VCA Inc.
WOOF
| $9.32M | 0.02% |
171,386
-676,127
| -80% | -$35.8M |
|
1023
Enerpac Tool Group
EPAC
$1.9B
| $9.29M | 0.02% |
+402,548
| New | +$9.63M |
|
|
ALEX
1024
DELISTED
Alexander & Baldwin
ALEX
| $9.27M | 0.02% |
+235,366
| New | +$9.68M |
|
|
SF
1025
Stifel
SF
$12.2B
| $9.24M | 0.02% |
360,160
+190,325
| +112% | +$4.69M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.